1Aronow WS. Optimal management of older patients with atrial fibrillation. Drugs Aging 1994.4:184-193.
2Aronow WS. Digoxin or angiotensin converting enzyme inhibitors for congestive heart failure in geriatric patients. Which is the preferred treatment?Drugs Aging 1991;1:98-103.
3Aronow WS. Prevalence of appropriate and inappropriate indications for use of digoxin in order patients at the time of admission to a nursing home. J Am Geriatr Soc 1996;44:.588 - 590.
4Hawkins CM, Richardson DW, Vokonas PS. Effect of propranolol in reducing mortality in older myocardial infarction patients. The Beta-Blocker Heart Attack Trial experience. Circulation 1983;67(suppl I):1-94-97,.
5Gundersen T, Abrahmsen AM, Kiekshus J et al. Timolol-related reduction in mortality and reinfarction in patients ages 65-73 years surviving acute myocardial infarction, Circulation 1982;66:1179- 1184.
6Hjalmarson A, Herlitz .J. Holmberg S et al. The Goteburg Metoprolol Trial:Effects on Mortality, and morbidity, in acute myocardial infarction Circulation 1983;67(supp1 I):1-26-31.
7Aronow WS, Ahn C. Mercando AD et al, Effect af propranolol versus no antiarrhythmic drug on sudden cardiac death, total cardiac death, and total death in patients ≥ 62 years of age with heart discase, complex ventricular arrhythmias, and left ventricular ejection fraction ≥40%. Am J Cardiol 1994;74:267-270.
8Park KC, Forman DE, Wei JY. Utility of hera-hlockade treatment for older postinfarction patients. J Am Geriatr Soc 1995;43;751-755.
91993 Joint National Committee. The Fifth Report of the Joint National Committee on the Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993.153:154-183.
10Aronow WS. Prevalence of use of beta blockers and of calcium channel blockers in older patients with prior myocardial infarction at the time of admission to a nursing home, J Am Geriatr Soc 1996;44:1075-1077.
